Sarepta Therapeutics Inc (NASDAQ:SRPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Recs

0
Player Avatar portefeuille (99.66) Submitted: 12/18/2012 10:53:32 PM : Outperform Start Price: $14.60 SRPT Score: +31.73

http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.

Featured Broker Partners


Advertisement